Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04423068Phase 1Completed
Phase 1, open-label trial in pregnancy, sponsored by Children's Mercy Kansas City. Primary endpoint: Feasibility of SexHealth II at 3 months. Started Dec 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04423068.